Israeli AI Picks Best Embryos For IVF Treatment
A fertility clinic in the UK will use Israeli tech to determine the best quality embryos for in-vitro fertilization (IVF) treatments.
IVF is only successful one-third of the time. Tel Aviv-based Fairtility is trying to increase the odds with its AI assistant CHLOE (Cultivating Human Life through Optimal Embryos), which helps clinicians determine the embryos with the greatest potential for implantation.
It generates an embryo quality score with insights and explanations based on millions of data points, which may improve IVF outcomes for patients at London’s Centre for Reproductive and Genetic Health (CRGH).
The tech is also powering the clinic’s new CRGH Insight tool, which lets embryologists share with patients real-time, uninterrupted video feed of their developing embryos.
Patients will be able to watch their embryos grow from a single cell into a fully developed blastocyst (cluster of rapidly dividing cells made by a fertilized egg).
“With CHLOE EQ’s transformative AI technology, CRGH Insight will empower both clinicians and patients with information and tools to increase visibility into the fertility journey,” said Eran Eshed, CEO of Fairtility.
“Providing this level of transparency can engender a more collaborative process between patients and IVF professionals and may allow patients to feel a greater sense of control in a process that can seem unpredictable.”
Jonathon Lawrence, CEO of CRGH, said: “We’re proud to work with Fairtility to provide our patients with a revolutionary level of insight.
“Not only is the technology incredibly impressive, the Fairtility team also know how to work with clinics such as ours to provide solutions which really enhance the patient experience. We are delighted that patients can now continuously track their embryos’ development.”